Titre : Prisons

Prisons : Questions médicales fréquentes

Termes MeSH sélectionnés :

Developing Countries
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Prisons : Questions médicales les plus fréquentes", "headline": "Prisons : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Prisons : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-06-15", "dateModified": "2025-03-12", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Prisons" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Établissements correctionnels", "url": "https://questionsmedicales.fr/mesh/D000081682", "about": { "@type": "MedicalCondition", "name": "Établissements correctionnels", "code": { "@type": "MedicalCode", "code": "D000081682", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "J03.220" } } }, "about": { "@type": "MedicalCondition", "name": "Prisons", "alternateName": "Prisons", "code": { "@type": "MedicalCode", "code": "D011330", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Philippa Tomczak", "url": "https://questionsmedicales.fr/author/Philippa%20Tomczak", "affiliation": { "@type": "Organization", "name": "University of Nottingham, UK." } }, { "@type": "Person", "name": "Omokehinde Olubunmi Fakorede", "url": "https://questionsmedicales.fr/author/Omokehinde%20Olubunmi%20Fakorede", "affiliation": { "@type": "Organization", "name": "Department of Mental Health and Behavioral Medicine, Federal Medical Centre, Idi-Aba, Ogun State, Nigeria." } }, { "@type": "Person", "name": "Peter Olutunde Onifade", "url": "https://questionsmedicales.fr/author/Peter%20Olutunde%20Onifade", "affiliation": { "@type": "Organization", "name": "Clinical Services, Neuropsychiatric Hospital, Abeokuta, Nigeria." } }, { "@type": "Person", "name": "Oluyinka Emmanuel Majekodunmi", "url": "https://questionsmedicales.fr/author/Oluyinka%20Emmanuel%20Majekodunmi", "affiliation": { "@type": "Organization", "name": "Clinical Services Department, Neuropsychiatric Hospital, Abeokuta, Nigeria." } }, { "@type": "Person", "name": "Adefunke Omosefe DadeMatthews", "url": "https://questionsmedicales.fr/author/Adefunke%20Omosefe%20DadeMatthews", "affiliation": { "@type": "Organization", "name": "Clinical Services, Neuropsychiatric Hospital, Abeokuta, Nigeria." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Association between the use of Sci-Hub and consultation of scientific journals by medical students from six Latin American countries: A secondary analysis.", "datePublished": "2023-07-05", "url": "https://questionsmedicales.fr/article/37600382", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.heliyon.2023.e17868" } }, { "@type": "ScholarlyArticle", "name": "Interventions targeting the mental health and wellbeing of care-experienced children and young people in higher-income countries: Evidence map and systematic review.", "datePublished": "2023-07-01", "url": "https://questionsmedicales.fr/article/37393358", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s13643-023-02260-y" } }, { "@type": "ScholarlyArticle", "name": "Treatment patterns and outcomes of patients with metastatic non-small cell lung cancer in five European countries: a real-world evidence survey.", "datePublished": "2023-06-30", "url": "https://questionsmedicales.fr/article/37386452", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s12885-023-11074-z" } }, { "@type": "ScholarlyArticle", "name": "Plastic Venture Builder (PVB): An empirically derived assessment tool to support plastic waste management ventures in low- and middle-income countries.", "datePublished": "2023-06-30", "url": "https://questionsmedicales.fr/article/37386896", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1177/0734242X231180648" } }, { "@type": "ScholarlyArticle", "name": "Algorithms and heuristics of health technology assessments: A retrospective analysis of factors associated with HTA outcomes for new drugs across seven OECD countries.", "datePublished": "2023-06-26", "url": "https://questionsmedicales.fr/article/37450991", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.socscimed.2023.116045" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Établissements non médicaux publics ou privés", "item": "https://questionsmedicales.fr/mesh/D000072182" }, { "@type": "ListItem", "position": 3, "name": "Établissements correctionnels", "item": "https://questionsmedicales.fr/mesh/D000081682" }, { "@type": "ListItem", "position": 4, "name": "Prisons", "item": "https://questionsmedicales.fr/mesh/D011330" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Prisons - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Prisons", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-12", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Prisons", "description": "Comment évaluer la santé mentale en prison ?\nQuels tests médicaux sont réalisés en prison ?\nComment détecter les addictions en prison ?\nQuelles sont les maladies courantes en prison ?\nComment identifier les problèmes de violence en prison ?", "url": "https://questionsmedicales.fr/mesh/D011330?mesh_terms=Developing+Countries&page=1000#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Prisons", "description": "Quels symptômes de dépression sont observés en prison ?\nComment se manifestent les troubles anxieux en prison ?\nQuels signes d'abus de substances sont visibles ?\nQuels symptômes physiques sont fréquents en prison ?\nComment reconnaître le stress post-traumatique en prison ?", "url": "https://questionsmedicales.fr/mesh/D011330?mesh_terms=Developing+Countries&page=1000#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Prisons", "description": "Comment prévenir les épidémies en prison ?\nQuelles stratégies de santé publique sont appliquées ?\nComment réduire la violence en prison ?\nQuelles sont les initiatives pour la santé mentale ?\nComment prévenir les suicides en prison ?", "url": "https://questionsmedicales.fr/mesh/D011330?mesh_terms=Developing+Countries&page=1000#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Prisons", "description": "Quels traitements sont offerts pour la santé mentale ?\nComment sont gérées les addictions en prison ?\nQuels soins médicaux sont accessibles aux détenus ?\nComment se déroule la réhabilitation en prison ?\nQuels traitements sont disponibles pour les maladies infectieuses ?", "url": "https://questionsmedicales.fr/mesh/D011330?mesh_terms=Developing+Countries&page=1000#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Prisons", "description": "Quelles complications peuvent survenir avec les maladies mentales ?\nQuels risques de santé sont liés à la surpopulation ?\nComment les conditions de vie affectent-elles la santé ?\nQuelles sont les conséquences des abus de substances ?\nQuels effets du stress chronique en prison ?", "url": "https://questionsmedicales.fr/mesh/D011330?mesh_terms=Developing+Countries&page=1000#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Prisons", "description": "Quels facteurs augmentent le risque de maladies mentales ?\nComment la violence en prison affecte-t-elle la santé ?\nQuels sont les risques liés à l'usage de drogues en prison ?\nComment la surpopulation carcérale influence-t-elle la santé ?\nQuels antécédents augmentent le risque de récidive ?", "url": "https://questionsmedicales.fr/mesh/D011330?mesh_terms=Developing+Countries&page=1000#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment évaluer la santé mentale en prison ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Des évaluations psychologiques régulières sont effectuées pour détecter les troubles." } }, { "@type": "Question", "name": "Quels tests médicaux sont réalisés en prison ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des bilans de santé, dépistages de maladies infectieuses et évaluations physiques sont courants." } }, { "@type": "Question", "name": "Comment détecter les addictions en prison ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Des questionnaires et des entretiens avec des professionnels de santé sont utilisés." } }, { "@type": "Question", "name": "Quelles sont les maladies courantes en prison ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Les infections respiratoires, les maladies de la peau et les troubles mentaux sont fréquents." } }, { "@type": "Question", "name": "Comment identifier les problèmes de violence en prison ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Des rapports d'incidents et des entretiens avec les détenus aident à évaluer la violence." } }, { "@type": "Question", "name": "Quels symptômes de dépression sont observés en prison ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent tristesse, perte d'intérêt, fatigue et troubles du sommeil." } }, { "@type": "Question", "name": "Comment se manifestent les troubles anxieux en prison ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Les détenus peuvent éprouver agitation, inquiétude excessive et troubles de la concentration." } }, { "@type": "Question", "name": "Quels signes d'abus de substances sont visibles ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Les signes incluent des changements de comportement, des problèmes de santé et des absences fréquentes." } }, { "@type": "Question", "name": "Quels symptômes physiques sont fréquents en prison ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Les douleurs chroniques, les infections cutanées et les problèmes respiratoires sont courants." } }, { "@type": "Question", "name": "Comment reconnaître le stress post-traumatique en prison ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent reviviscences, évitement et hypervigilance chez les détenus." } }, { "@type": "Question", "name": "Comment prévenir les épidémies en prison ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Des mesures d'hygiène strictes et des vaccinations sont mises en œuvre pour prévenir les épidémies." } }, { "@type": "Question", "name": "Quelles stratégies de santé publique sont appliquées ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Des programmes de sensibilisation et d'éducation à la santé sont organisés pour les détenus." } }, { "@type": "Question", "name": "Comment réduire la violence en prison ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Des formations sur la gestion des conflits et des programmes de médiation sont proposés." } }, { "@type": "Question", "name": "Quelles sont les initiatives pour la santé mentale ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Des campagnes de sensibilisation et des services de soutien psychologique sont mis en place." } }, { "@type": "Question", "name": "Comment prévenir les suicides en prison ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Des évaluations régulières et des programmes de prévention du suicide sont essentiels." } }, { "@type": "Question", "name": "Quels traitements sont offerts pour la santé mentale ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Des thérapies individuelles, des groupes de soutien et des médicaments sont disponibles." } }, { "@type": "Question", "name": "Comment sont gérées les addictions en prison ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Des programmes de désintoxication et de soutien psychologique sont mis en place." } }, { "@type": "Question", "name": "Quels soins médicaux sont accessibles aux détenus ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Les détenus ont accès à des soins médicaux de base, y compris des consultations spécialisées." } }, { "@type": "Question", "name": "Comment se déroule la réhabilitation en prison ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Des programmes éducatifs et de formation professionnelle sont proposés pour favoriser la réinsertion." } }, { "@type": "Question", "name": "Quels traitements sont disponibles pour les maladies infectieuses ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Des traitements antiviraux et antibiotiques sont administrés selon les besoins médicaux." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir avec les maladies mentales ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Les complications incluent l'isolement social, la violence et les comportements autodestructeurs." } }, { "@type": "Question", "name": "Quels risques de santé sont liés à la surpopulation ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "La surpopulation augmente le risque de maladies infectieuses et de stress psychologique." } }, { "@type": "Question", "name": "Comment les conditions de vie affectent-elles la santé ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Des conditions de vie précaires peuvent entraîner des problèmes de santé physique et mentale." } }, { "@type": "Question", "name": "Quelles sont les conséquences des abus de substances ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Les abus peuvent entraîner des problèmes de santé chroniques et des comportements criminels." } }, { "@type": "Question", "name": "Quels effets du stress chronique en prison ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Le stress chronique peut provoquer des troubles mentaux, des maladies cardiovasculaires et des troubles du sommeil." } }, { "@type": "Question", "name": "Quels facteurs augmentent le risque de maladies mentales ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "L'isolement, le passé criminel et les antécédents familiaux de troubles mentaux sont des facteurs de risque." } }, { "@type": "Question", "name": "Comment la violence en prison affecte-t-elle la santé ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "La violence augmente le risque de traumatismes physiques et psychologiques chez les détenus." } }, { "@type": "Question", "name": "Quels sont les risques liés à l'usage de drogues en prison ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "L'usage de drogues peut entraîner des infections, des overdoses et des problèmes de santé mentale." } }, { "@type": "Question", "name": "Comment la surpopulation carcérale influence-t-elle la santé ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "La surpopulation favorise la transmission de maladies et augmente le stress psychologique." } }, { "@type": "Question", "name": "Quels antécédents augmentent le risque de récidive ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Les antécédents criminels, les problèmes de santé mentale et l'absence de soutien social sont des facteurs de risque." } } ] } ] }

Sources (10000 au total)

Association between the use of Sci-Hub and consultation of scientific journals by medical students from six Latin American countries: A secondary analysis.

Sci-Hub is a website that allows users to download full-text versions of millions of scientific articles for free. The objective of this study was to evaluate the association between the use of Sci-Hu... We conducted a secondary analysis of data from a 2017 cross-sectional study of medical students from six Latin American countries (Argentina, Bolivia, Chile, Colombia, Paraguay, and Peru). Consultatio... Of the 6632 participants, 38.2% consulted scientific journals and 10.3% used Sci-Hub once a week. Using Sci-Hub at least once a week was associated with a 20% increase in the prevalence of consulting ... Amongst medical students surveyed from the above six Latin American countries, the use of Sci-Hub at least once a week was significantly associated with the self-reported prevalence of consulting scie...

Interventions targeting the mental health and wellbeing of care-experienced children and young people in higher-income countries: Evidence map and systematic review.

The mental health and wellbeing of care-experienced children and young people (i.e. foster care, kinship care, residential care) is poorer than non-care-experienced populations. The Care-experienced c... For the first phase of the review, we constructed an evidence map identifying key clusters and gaps in interventions and evaluations. Studies were identified through 16 electronic databases and 22 hea... In total, 64 interventions with 124 associated study reports were eligible. The majority of study reports were from the USA (n = 77). Interventions primarily targeted children and young people's skill... Future intervention development might focus on structural-level intervention theories and components, and target outcomes related to subjective wellbeing and suicide. In accordance with current method... PROSPERO CRD42020177478....

Treatment patterns and outcomes of patients with metastatic non-small cell lung cancer in five European countries: a real-world evidence survey.

The landscape of non-small cell lung cancer (NSCLC) therapy is rapidly changing. This analysis aimed to understand patient characteristics, diagnosis and treatment patterns in patients with metastatic... Data were drawn from the Adelphi NSCLC Disease Specific Programme™, a point-in-time survey of oncologists/pulmonologists and their consulting patients in France, Germany, Italy, Spain and UK. Physicia... Mean (standard deviation [SD]) age for 1073 patients with EGFR-wild-type/ALK-wild-type mNSCLC was 66.2 (8.9) years, 65.2% were male and 63.7% had adenocarcinoma. Level of PD-L1 expression at advanced ... Real-world treatment patterns suggest that chemotherapy use remains high despite guidelines recommending immunotherapy-based 1L treatment for mNSCLC. QoL reported by patients was generally lower than ...

Algorithms and heuristics of health technology assessments: A retrospective analysis of factors associated with HTA outcomes for new drugs across seven OECD countries.

Positive health technology assessment (HTA) outcomes can have important implications for equity, efficiency and timely patient access to novel therapies. Several outcomes and dimensions of benefit bey... We analyse a proprietary dataset of HTA outcomes in 7 countries, to (a) test whether HTA decision-making is grounded in welfarist or extra-welfarist approaches; and (b) empirically determine the facto... Data were extracted from publicly available HTA reports on drugs that received marketing authorisation between 2009 and 2018 (N = 1415). The outcomes of interest were the probability of positive HTA o... Positive HTA outcomes accounted for 87.3% of the sample (n = 1235), of which 71% (n = 1004) were restricted. Drugs with positive HTA outcomes were subject to clinical restrictions (n = 652, 46%), fina... Our results are contextual and reinforce arguments in favour of explicitly accounting for social value judgements, establishing separate assessment frameworks for highly uncertain products, adopting r...

Out-of-pocket expenditure on community healthcare services at end-of-life among decedents from cardiovascular disease in six European countries and Israel.

Most people who develop chronic diseases, including cardiovascular disease (CVD), live in their homes in the community in their last year of life. Since cost-sharing is common in most countries, inclu... SHARE data among people aged 50 + from seven European countries (including Israel) who died from CVD are analyzed. Decedents' family members are interviewed to learn about OOPE on their relatives' acc... We identified 1,335 individuals who had died from CVD (average age 80.8 years, 54% men). More than half of CVD-decedent people spend OOPE on community services at EOL and their expenditure varies wide... Since improving CVD care efficiency and effectiveness are key aims, healthcare policymakers should broaden the investigation into expanding public funding for community services in order to mitigate O...

Sex differences in hepatitis A incidence rates-a multi-year pooled-analysis based on national data from nine high-income countries.

Possible sex differences in hepatitis A virus (HAV) incidence rates in different age groups are not well documented. We aimed to obtain stable pooled estimates of such differences based on data from a... We obtained data on incident cases of HAV by sex and age group over a period of 6-25 years from nine countries: Australia, Canada, Czech Republic, Finland, Germany, Israel, Netherland, New Zealand and... A male excess in incidence rates was consistently observed in all age groups, although in the youngest and oldest age groups, where the numbers tended to be lower, the lower bounds of the 95% confiden... The excess HAV incidence rates in young males, pooled over a number of countries, suggest that the sex differences are likely to be due at least in part to physiological and biological differences and...